Actelion Chooses GENEART as Exclusive Supplier for DNA Engineering & Processing Services
Framework agreement with Actelion Pharmaceuticals Ltd. signed
"Gene optimization and gene synthesis offer many advantages over conventional methods in molecular biology. For instance, genes can be tailored to the respective customer project by our GeneOptimizer® software without any restrictions and subsequently produced within a few days. This not only shortens development times for biopharmaceuticals, but also increases the yield and thus reduces production and project costs. The fully DIN EN ISO 9001:2000 certified processes of GENEART and the world-wide highest production capacities additionally ensure reliable and quick processing of customer projects with observance of the required quality standards for the development of pharmaceutical agents", Prof. Dr. Ralf Wagner, CEO of GENEART AG, explains.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.